DK0747058T3 - Acellulær vaccine - Google Patents

Acellulær vaccine

Info

Publication number
DK0747058T3
DK0747058T3 DK96112324T DK96112324T DK0747058T3 DK 0747058 T3 DK0747058 T3 DK 0747058T3 DK 96112324 T DK96112324 T DK 96112324T DK 96112324 T DK96112324 T DK 96112324T DK 0747058 T3 DK0747058 T3 DK 0747058T3
Authority
DK
Denmark
Prior art keywords
vaccine
acellular vaccine
antigens
acellular
pertussis
Prior art date
Application number
DK96112324T
Other languages
Danish (da)
English (en)
Inventor
Pavel Novotny
Original Assignee
Medeva Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10656410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0747058(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medeva Bv filed Critical Medeva Bv
Application granted granted Critical
Publication of DK0747058T3 publication Critical patent/DK0747058T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Liquid Crystal Substances (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
DK96112324T 1989-05-08 1990-04-26 Acellulær vaccine DK0747058T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898910570A GB8910570D0 (en) 1989-05-08 1989-05-08 Acellular vaccine
EP90907222A EP0471726B2 (fr) 1989-05-08 1990-04-26 Vaccin acellulaire

Publications (1)

Publication Number Publication Date
DK0747058T3 true DK0747058T3 (da) 2005-01-10

Family

ID=10656410

Family Applications (3)

Application Number Title Priority Date Filing Date
DK04018329T DK1666057T3 (da) 1989-05-08 1990-04-26 Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
DK96112324T DK0747058T3 (da) 1989-05-08 1990-04-26 Acellulær vaccine
DK90907222T DK0471726T4 (da) 1989-05-08 1990-04-26 Acellulær vaccine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK04018329T DK1666057T3 (da) 1989-05-08 1990-04-26 Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK90907222T DK0471726T4 (da) 1989-05-08 1990-04-26 Acellulær vaccine

Country Status (12)

Country Link
US (1) US7479283B1 (fr)
EP (3) EP0471726B2 (fr)
JP (2) JP3281369B2 (fr)
AT (3) ATE147271T1 (fr)
DE (14) DE122005000014I1 (fr)
DK (3) DK1666057T3 (fr)
ES (3) ES2322352T3 (fr)
FR (1) FR09C0033I1 (fr)
GB (1) GB8910570D0 (fr)
LU (15) LU90204I2 (fr)
NL (13) NL980007I1 (fr)
WO (1) WO1990013313A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
GB9021004D0 (en) * 1990-09-27 1990-11-07 Wellcome Found Acellular vaccines
GB9209118D0 (en) * 1992-04-28 1992-06-10 Sb 120 Amsterdam Bv Vaccine compositions
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
US7022522B2 (en) 1998-11-13 2006-04-04 Limin Guan Macroporous polymer scaffold containing calcium phosphate particles
EP1667712B1 (fr) * 2003-10-02 2010-07-21 GlaxoSmithKline Biologicals S.A. Antigenes de b. pertussis et leur utilisation dans la vaccination
US8877201B2 (en) 2007-10-25 2014-11-04 Wake Forest University Health Sciences Bordetella outer-membrane protein antigens and methods of making and using the same
WO2009114397A2 (fr) 2008-03-07 2009-09-17 Arkema Inc. Systèmes formulés et stables contenant du chloro-3,3,3-trifluoropropène
GB201105981D0 (en) 2011-04-08 2011-05-18 Glaxosmithkline Biolog Sa Novel process
BR112015021523A8 (pt) 2013-03-08 2021-06-29 Crucell Holland Bv composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
KR101905278B1 (ko) 2013-09-08 2018-10-08 화이자 인코포레이티드 나이세리아 메닌지티디스 조성물 및 그의 방법
EP3270959A1 (fr) 2015-02-19 2018-01-24 Pfizer Inc Compositions de neisseria meningitidis et méthodes associées

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2047886A1 (en) 1969-06-30 1971-03-19 Merieux Inst Non-toxic anti-whooping cough vaccine
EP0043349B1 (fr) 1980-06-27 1987-08-12 Ciba-Geigy Ag Agents synergiques et procédé pour combattre sélectivement les mauvaises herbes, particulièrement dans les cultures de céréales et de soya
JPS5750925A (en) 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
JPS58222032A (ja) 1982-06-18 1983-12-23 Teijin Ltd 百日咳毒素のサブユニツト蛋白
GB8412207D0 (en) 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US5237052A (en) * 1984-05-12 1993-08-17 Burroughs Wellcome Company Antigenic preparations and isolation of such preparations
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
FR2590483B1 (fr) 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
DE3783869D1 (de) * 1986-11-11 1993-03-11 Siemens Ag Flusskompensierter stromwandler.
FR2606789B1 (fr) 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
EP0267998A1 (fr) * 1986-11-17 1988-05-25 Institut Pasteur Moyens de protection contre l'infection et l'intoxication par bordetella
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
US5162223A (en) * 1989-02-17 1992-11-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Resources Hybridomas and resulting monoclonal antibodies directed against antigens of Bordetella pertussis
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5276142A (en) 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
GB9007416D0 (en) 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9007657D0 (en) 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
IT1248735B (it) 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
EP0484621A3 (en) 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
ES2136290T3 (es) 1994-04-28 1999-11-16 Takeda Chemical Industries Ltd Metodo para separar componentes protectores de bordetella pertussis.
US5972225A (en) * 1996-05-07 1999-10-26 Cook Imaging Corporation Process for remediating endotoxin-contaminated bulk non-ionic contrast media

Also Published As

Publication number Publication date
NL980007I1 (nl) 1998-04-01
ES2230555T3 (es) 2005-05-01
DE69034166D1 (de) 2004-10-28
NL300403I1 (en) 2009-10-01
EP1666057A2 (fr) 2006-06-07
EP0471726B1 (fr) 1997-01-08
FR09C0033I1 (fr) 2009-09-25
NL300400I1 (en) 2009-10-01
DE122009000043I1 (de) 2009-11-05
DE69029656T3 (de) 2009-06-04
ATE276759T1 (de) 2004-10-15
NL300401I1 (en) 2009-10-01
EP1666057A3 (fr) 2008-06-04
LU91595I2 (fr) 2009-10-12
DE122005000016I1 (de) 2005-06-23
JP3281369B2 (ja) 2002-05-13
LU91149I2 (fr) 2005-06-23
LU91593I2 (fr) 2009-10-12
DE122005000015I1 (de) 2005-11-24
LU91152I2 (fr) 2005-06-23
LU91594I2 (fr) 2009-10-12
ATE147271T1 (de) 1997-01-15
US7479283B1 (en) 2009-01-20
GB8910570D0 (en) 1989-06-21
LU91154I2 (fr) 2005-06-23
NL300184I1 (nl) 2005-06-01
LU91592I2 (fr) 2009-10-12
EP0471726B2 (fr) 2008-05-14
NL300189I1 (nl) 2005-06-01
DE122009000042I1 (de) 2009-11-05
EP0747058B1 (fr) 2004-09-22
JPH04505158A (ja) 1992-09-10
LU91150I2 (fr) 2005-06-23
ES2322352T3 (es) 2009-06-19
DE122005000019I1 (de) 2005-06-23
EP1666057B1 (fr) 2009-02-18
DE122005000017I1 (de) 2005-06-23
DE122005000020I1 (de) 2005-06-23
ES2095874T3 (es) 1997-03-01
ES2095874T5 (es) 2008-11-01
DE122005000018I1 (de) 2005-06-23
DE69029656T2 (de) 1997-04-24
DE69034264D1 (de) 2009-04-02
ATE422900T1 (de) 2009-03-15
DK0471726T4 (da) 2008-09-15
LU91155I2 (fr) 2005-06-23
LU90204I2 (fr) 1998-04-06
NL300185I1 (nl) 2005-06-01
EP0471726A1 (fr) 1992-02-26
DE122009000041I1 (de) 2009-11-05
JP2002226397A (ja) 2002-08-14
LU91591I2 (fr) 2009-10-12
NL300402I1 (en) 2009-10-01
DE69029656D1 (de) 1997-02-20
LU91596I2 (fr) 2009-10-12
NL300187I1 (nl) 2005-06-01
DK0471726T3 (da) 1997-03-03
DE69034166T2 (de) 2005-08-04
DK1666057T3 (da) 2009-06-08
LU91151I2 (fr) 2005-06-23
DE122009000044I1 (de) 2009-11-05
LU91597I2 (fr) 2009-10-12
LU91153I2 (fr) 2005-06-23
NL300404I1 (en) 2009-10-01
DE122005000014I1 (de) 2005-06-23
WO1990013313A1 (fr) 1990-11-15
NL300186I1 (nl) 2005-06-01
EP0747058A1 (fr) 1996-12-11
NL300188I1 (nl) 2005-06-01
NL300183I1 (nl) 2005-06-01

Similar Documents

Publication Publication Date Title
NL300189I1 (nl) Acellulair vaccin.